Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

Michel Attal, Jean‐François Rossi, Philippe Casassus et al. · New England Journal of Medicine · 1996 · 2.6K citations · Full text

Medicine, Hematology, Oncology +14

A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA

M Ichel A Ttal, J Ean, A.A. D uuml nne et al. · 2013 · 2.2K citations

Medicine, Hematology, Oncology +14

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

J. A. Child, Gareth J. Morgan, Faith E. Davies et al. · New England Journal of Medicine · 2003 · 1.8K citations · Full text

Medicine, Hematology, Oncology +17

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 916 citations

Life Sciences, Genetics, Molecular Biology +12

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 905 citations · Full text

Medicine, Genetics, Hematology +15